SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-001739
Filing Date
2021-09-09
Accepted
2021-09-09 16:11:04
Documents
13
Period of Report
2021-09-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20210909.htm   iXBRL 8-K 56566
2 EX-99.1 rlyb-20210909ex99_1.htm EX-99.1 184393
  Complete submission text file 0000950170-21-001739.txt   375653

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20210909.xsd EX-101.SCH 2487
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20210909_lab.xml EX-101.LAB 14046
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20210909_pre.xml EX-101.PRE 11509
6 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20210909_htm.xml XML 4890
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 211244535
SIC: 2834 Pharmaceutical Preparations